Dapsone (By mouth)


Updated 09/04/08 11:41 PM · Posted by · 0 comments

HEALTH GUIDE REFERENCE FROM A.D.A.M

Introduction

Dapsone (DAP-sone)

Treats leprosy and a skin problem called dermatitis herpetiformis. Sometimes used to treat malaria and AIDS-related pneumonia. Belongs to a class of drugs called sulfone antibiotics.

Brand Name(s)

Dapsone

There may be other brand names for this medicine.

When This Medicine Should Not Be Used

You should not use this medicine if you have ever had an allergic reaction to dapsone.

How to Use This Medicine

Tablet

  • Take this medicine exactly as ordered by your doctor.
  • May be taken with food to reduce stomach upset.

If a dose is missed:

  • Take the missed dose as soon as possible.
  • Skip the missed dose if it is almost time for your next dose.
  • You should not use two doses at the same time.

How to Store and Dispose of This Medicine

  • Store at room temperature in a closed container, away from heat, moisture, and direct light.
  • Keep all medicine out of the reach of children.

Drugs and Foods to Avoid

Ask your doctor or pharmacist before using any other medicine, including over-the-counter medicines, vitamins, and herbal products.

Warnings While Using This Medicine

  • If you are pregnant or breastfeeding, talk to your doctor before taking dapsone.
  • Check with your doctor before taking dapsone if you have anemia, or liver or kidney disease.
  • Tell your doctor if you are allergic to sulfa drugs.
  • Your doctor may give you a schedule for regular blood tests. This schedule should be carefully followed.
  • Dapsone may make you dizzy. Be careful when driving a car or using machinery.

Possible Side Effects While Using This Medicine

Call your doctor right away if you notice any of these side effects:

  • Severe skin rash
  • Fever, sore throat
  • Muscle weakness
  • Yellowing of skin or eyes

If you notice these less serious side effects, talk with your doctor:

  • Nausea, vomiting
  • Loss of appetite
  • Headache
  • Nervousness
  • Dizziness
Source Doc: 45_0513
Join The Conversation:
powered by
Please sign in to comment.